NEVRALIP 600 RETARD

30 tablets

Nevralip™ 600 is a dietary supplement based on PeaMin (an exclusive combination of 600 mg of PEA, chromium and B vitamins) and a pool of antioxidants (selenium, zinc and vitamin E). Nevralip™ 600 retard is formulated with T-Matrix Lipid, in a special lipophilic matrix that allows for prolonged release of the components, in order to ensure greater bioavailability of the active ingredients and maximise their effectiveness. Translated with DeepL.com (free version)

Description

Nevralip 600 Retard is used in all clinical situations characterised by altered peripheral nerve trophism. It is also used in all situations of hyperglycaemia, improving cell sensitivity to insulin and blood glucose management.

Pharmaceutical form

Tablets - Pack of 30 tablets of 1.15 g each. - Gluten-Free.

Application

We recommend taking 1 tablet a day, preferably on an empty stomach.

Information / Warnings

Food Supplements are not intended as a substitute for a varied, balanced diet and a healthy lifestyle.
Do not exceed the recommended daily dose.
Keep out of the reach of children under 3 years of age.
Do not use during pregnancy and lactation.

Nutritional table

Contenuti medi per dose giornaliera (1 compressa)
Contenuti mediPer dose giornaliera (1 cpr)%VNR*
Palmitoiletanolamide (PEA)600 mg
Vitamina E (alfa-TE)15 mg125
Zinco10 mg100
Acido Pantotenico9 mg150
Vitamina B63 mg214
Tiamina2 mg182
Picolinato di Cromo0,83 mg
pari a Cromo100 µg250
Biotina100 µg200
Selenio50 µg91
*VNR: Valori Nutritivi di Riferimento

You may also be interested in:

River Pharma products represent progress for the Medical-Scientific Community, as well as the response to the most widespread ailments and diseases in the world.

SYALOX 300 PLUS

SYALOX 300 PLUS

Syalox 300 Plus is indicated in all clinical situations characterised by joint pain and reduced mobility.

Discover the product
NEVRALCAR DUO

NEVRALCAR DUO

The Synergy of the 2 Active Ingredients allow pain control in all those clinical situations characterized by Neuropathy of both joint and metabolic origin.

Discover the product

River Pharma: Healthcare is Our Passion

Nutraceuticals

State-of-the-art products based on high molecular weight Hyaluronic Acid obtained through bio-fermentation technology and are characterised by their effectiveness proven in five distinct therapeutic areas.

Find out more

Medical Devices

The latest generation of medical devices based on Hyaluronic Acid with a high molecular weight, 2 mil D, to be injected, effective for the treatment and prevention of osteoarticular pathologies linked to ageing and for the treatment of acute trauma. 

Find out more

Dermocosmetics

Products that contain, Hyaluronic Acids with a careful selection of molecular weight, amongst other things and are characterised by their anti-ageing effectiveness.

Find out more

Science Informs: The River Pharma Blog

Stay up to date, learn more about the research and insights of the most authoritative members of the International Medical-Scientific Community.

Menopause and osteoporosis: what causes bone loss?

Menopause and osteoporosis: what causes bone loss?

Unfortunately for all women who are in menopause osteoporosis is a sad reality that sooner or later will become increasingly present in their lives, this is even more true in all those who already have a genetic predisposition towards this degenerative bone disease.

Keep reading

Iscriviti alla nostra Newsletter

Il tuo appuntamento con la Scienza non si ferma mai. Registrati e rimani sempre aggiornato sulle notizie, gli approfondimenti, gli studi e le soluzioni terapeutiche più all’avanguardia.